부산대학교 도서관

Marín-Palma, Damariz; Tabares-Guevara, Jorge H.; Taborda, Natalia; Rugeles, Maria T.; Hernandez, Juan C.

Journal of Inflammation. 21(1)

Damariz Marín-Palma; Geysson Javier Fernandez; Julian Ruiz-Saenz; Natalia A. Taborda; Maria T. Rugeles; Juan C. Hernandez

Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)

Wbeimar Aguilar-Jiménez; Lizdany Flórez-Álvarez; Daniel S. Rincón; Damariz Marín-Palma; Alexandra Sánchez-Martínez; Jahnnyer Martínez; María Isabel Zapata; John D. Loaiza; Constanza Cárdenas; Fanny Guzmán; Paula A. Velilla; Natalia A. Taborda; Wildeman Zapata; Juan C. Hernández; Francisco J. Díaz; María T. Rugeles

Biomedica
Biomédica: revista del Instituto Nacional de Salud, Vol 41, Iss Sp. 2, Pp 86-102 (2021)
1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. https://doi.org/10.1056/NEJMoa2001316
2. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23. https://doi.org/10.1002/jmv.25681
3. Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60:102976. https://doi.org/10.1016/j.ebiom.2020.102976
4. Chu H, Chan JFW, Wang Y, Yuen TT, Chai Y, Hou Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 2020;71:1400-9. https://doi.org/10.1093/cid/ciaa410
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
6. Yuan X, Tong X, Wang Y, Wang H, Wang L, Xu X. Coagulopathy in elderly patients with coronavirus disease 2019. AGING Med. 2020;3:260-5. https://doi.org/10.1002/agm2.12133
7. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:1-11. https://doi.org/10.1080/10408363.2020.1770685
8. Taborda NA, Hern ndez JC, Montoya CJ, Rugeles MT. Natural killer cells and their role in the immune response during human immunodeficiency virus type-1 infection. Inmunologia. 2014;33:11-20. https://doi.org/10.1016/j.inmuno.2013.11.002
9. Alrubayyi A. NK cells in COVID-19: Protectors or opponents? Nat Rev Immunol. 2020;20:520. https://doi.org/10.1038/s41577-020-0408-0
11. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity. 2015;42:443-56. https://doi.org/10.1016/j.immuni.2015.02.008
12. Fl rez- lvarez L, Blanquiceth Y, Contreras K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
13. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533-5. https://doi.org/10.1038/s41423-020-0402-2
14. Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-8. https://doi.org/10.1080/22221751.2020.1762515
15. Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020;130:5235-44. https://doi.org/10.1172/JCI138759
16. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J Intensive Care. 2020;8:1-10. https://doi.org/10.1186/s40560-020-00453-4
17. Centers for Disease Control and Prevention-CDC. Real-time RT-PCR Primers and Probes for COVID-19. Accessed on: April 2, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html
18. Feria MG, Taborda NA, Hern ndez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS ONE. 2018;13:e0192845. https://doi.org/10.1371/journal.pone.0192845
19. Fl rez- lvarez L, Blanquiceth Y, Ram rez K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
20. D az FJ, Aguilar-Jim nez W, Fl rez- lvarez L, Valencia G, Laiton-Donato K, Franco-Mu oz C, et al. Aislamiento y caracterizaci n de una cepa temprana de SARS-CoV-2 durante la epidemia de 2020 en Medell n, Colombia. Biom dica. 2020;40(Supl.2):148-58. https://doi.org/10.7705/biomedica.5834
21. Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586-92. https://doi.org/10.1126/science.abd4251
22. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779-82. https://doi.org/10.1126/science.abb7498
23. Luna OF, G mez J, C rdenas C, Albericio F, Marshall SH, Guzm n F. Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine? Molecules. 2016;21:1-12. https://doi.org/10.3390/molecules21111542
24. Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT. An altered cytotoxic program of CD8 + T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE. 2019;14:1-24. https://doi.org/10.1371/journal.pone.0210540
25. Roederer M, Nozzi JL, Nason MC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytom Part A. 2011;79:167-74. https://doi.org/10.1002/cyto.a.21015
26. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343-60. https://doi.org/10.1631/jzus.B2000083
27. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011-9. https://doi.org/10.1007/s10096-020-03874-z
28. Garc a LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:4-8. https://doi.org/10.3389/fimmu.2020.01441
29. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy Eur J Allergy Clin Immunol. 2020;75:1564-81. https://doi.org/10.1111/all.14364
30. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971-7.e3. https://doi.org/10.1016/j.immuni.2020.04.023
31. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117:9490-6. https://doi.org/10.1073/pnas.2004168117
32. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 in patients and convalescent patients. Clin Infect Dis. 2020;71:2688-94. https://doi.org/10.1093/cid/ciaa721
33. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-4. https://doi.org/10.1038/s41591-020-0965-6
34. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-8. https://doi:10.1093/cid/ciaa248
35. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123-30. https://doi.org/10.1080/22221751.2020.1770129
36. Le Garff-Tavernier M, B ziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. 2010;9:527-35. https://doi.org/10.1111/j.1474-9726.2010.00584.x
37. Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, et al. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020;97:313-21. https://doi.org/10.1016/j.ijid.2020.05.106
38. Payen D, Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, et al. A longitudinal study of immune cells in severe COVID-19 patients. Front Immunol. 2020:11:580250. https://doi.org/10.3389/fimmu.2020.580250
39. Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020:130:4694-703. https://doi:10.1172/jci138554
40. Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541-3. https://doi.org/10.1038/s41423-020-0401-3
41. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:1-17. https://doi.org/10.1038/s41467-020-17292-4
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Biomédica, Volume: 41 Supplement 2, Pages: 102-86, Published: 15 OCT 2021

León, Kevin; Marín-Palma, Damariz; Gallego, Salomón; Yepes, Cristina; Vélez, Jhonatan; Castro, Gustavo A.; Jaimes, Fabián; Taborda, Natalia; Rugeles, María Teresa; Hernández, Juan C.; Hernández, Juan Carlos

Biomedica
Biomédica: revista del Instituto Nacional de Salud, Vol 42, Iss 2, Pp 239-241 (2022)
1. Walker BD. Elite control of HIV Infection: Implications for vaccines and treatment. Top HIV Med. 2007;15:134-6.
2. Gonzalo-Gil E, Ikediobi U, Sutton RE. Mechanisms of virologic control and clinical characteristics of HIV+ elite/viremic controllers. Yale J Biol Med. 2017;90:245-59.
3. Deeks S, Tracy R, Douek D. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39:633-45. https://doi.org/10.1016/j.immuni.2013.10.001.Systemic
4. Deeks S. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;14:118-23
5. Lucas S, Nelson AM. HIV and the spectrum of human disease. J Pathol. 2015;235:229-41. https://doi.org/10.1002/path.4449
6. Kedzierska K, Crowe SM. Cytokines and HIV-1: Interactions and clinical implications. Antivir Chem Chemother. 2001;12:133-50. https://doi.org/10.1177/095632020101200301
7. Ahmad R, Sindhu STA, Toma E, Morisset R, Ahmad A. Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: Role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. J Virol. 2002;76:12448-56. https://doi.org/10.1128/jvi.76.24.12448-12456.2002
8. Granowitz E V, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: Blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol Med. 1995;1:667-77. https://doi.org/10.1007/bf03401607
9. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, et al. Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci U S A. 1998;95:12550-5. https://doi.org/10.1073/pnas.95.21.12550
11. Martínez GJ, Celermajer DS, Patel S. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262-71. https://doi.org/10.1016/j.atherosclerosis.2017.12.027
12. Mullis C, Swartz TH. NLRP3 Inflammasome signaling as a link between HIV-1 infection and atherosclerotic cardiovascular disease. Front Cardiovasc Med. 2020;7:1-11. https://doi.org/10.3389/fcvm.2020.00095
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Biomédica, Volume: 42, Issue: 2, Pages: 329-341, Published: 01 JUN 2022

Damariz Marín-Palma; Jorge H. Tabares-Guevara; María I. Zapata-Cardona; Wildeman Zapata-Builes; Natalia Taborda; Maria T. Rugeles; Juan C. Hernandez

Front Immunol
Frontiers in Immunology, Vol 14 (2023)

Marín Palma, Leidy Damariz; Cardona Arias, Jaiberth Antonio; Hernández, Juan Carlos

Revista Ciencias de la Salud, Vol 17, Iss 2 (2019)
1. Im H, Ammit AJ. The NLRP3 inflammasome: role in airway inflammation. Clin Exp Allergy. 2014;44(2):160-72. Doi: 10.1111/cea.12206
2. Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407-20. Doi: 10.1038/nri.2016.58
3. McIntire CR, Yeretssian G, Saleh M. Inflammasomes in infection and inflammation. Apoptosis 2009;14(4):522-35. Doi: 10.1007/s10495-009-0312-3
4. Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, et al. Association of mutations in the nalp3/cias1/pypaf1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002;46(9):2445-52. Doi: 10.1002/art.10509
5. Hernandez JC, Latz E, Urcuqui-Inchima S. hiv-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology. 2014;57(1):36-42. Doi: 10.1159/000353902
6. Boasso A, Shearer GM. Chronic innate immune activation as a cause of hiv-1 immunopathogenesis. Clin Immunol. 2008;126(3):235-42. Doi: 10.1016/j.clim.2007.08.015
7. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in hiv-1 infection is associated with progression to aids. Aids. 2003;17(13):1881-8. Doi: 10.1097/01.aids.0000076311.76477.6e
8. Neuhaus J, Jacobs DR, Jr., Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with hiv infection. J Infect Dis. 2010;201(12):1788-95. Doi: 10.1086/652749
9. Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. Interleukin 1 induces hiv-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol Med. 1995;1(6):667-77. Doi: 10.1007/BF03401607
11. Feria MG, Taborda NA, Hernández JC, Rugeles MT. hiv replication is associated to inflammasomes activation, il-1beta, il-18 and caspase-1 expression in galt and peripheral blood. PLoS One. 2018;13(4):e0192845. Doi: 10.1371/journal.pone.0192845
12. Marín-Palma D, Taborda N, Urcuqui-Inchima S, Hernández J. Inflamación y respuesta inmune innata: Participación de las lipoproteínas de alta densidad. IATREIA. 2017 Oct-Dic;30(4):423-35. Doi: 10.17533/udea.iatreia.v30n4a06
13. Rangaswamy KS. Correlation between High-density Lipoprotein Cholesterol Level and cd4 Cell Count in hiv Patients on nnrti-Based art Regimen at Tertiary Care Hospital in Mysuru. Int J Sci Stud. 2017;5(3):150-4. Doi: 10.17354/ijss/2017/286
14. Marín-Palma D, Castro G, Cardona-Arias J, Urcuqui-Inchima S, Hernández J. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type I Infection Are Associated with Increased Inflammatory Markers and Disease Progression. Front Immunol. 2018;9:1350. Doi: 10.3389/fimmu.2018.01350
15. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine. 2008;5(10):e203. Doi: 10.1371/journal.pmed.0050203
16. Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ, Jr., et al. Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. The Journal of infectious diseases. 2015;212(7):1100-10. Doi: 10.1093/infdis/jiv159
17. Eckard AR, Rosebush JC, O’Riordan MA, Graves CC, Alexander A, Grover AK, et al. Neurocognitive dysfunction in hiv-infected youth: investigating the relationship with immune activation. Antivir Ther 2017;22(8):669-80. Doi: 10.3851/IMP3157
18. Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Plasma interleukin-18 is associated with viral load and disease progression in hiv-1-infected patients. Microbes Infect. 2004;6(14):1273-7. Doi: 10.1016/j.micinf.2004.07.009
19. Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, et al. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016;149(3):306-19. Doi: 10.1111/imm.12638
20. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3(6):920-40. Doi: 10.3390/v3060920
21. Socias ME, Sued O, Laufer N, Lazaro ME, Mingrone H, Pryluka D, et al. Acute retroviral syndrome and high baseline viral load are predictors of rapid hiv progression among untreated Argentinean seroconverters. J Int AIDS Soc. 2011;14:40. Doi: 10.1186/1758-2652-14-40
22. Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, et al. Biomarkers of Progression after hiv Acute/Early Infection: Nothing Compares to cd4(+) T-cell Count? Viruses. 2018;10(1). Doi: 10.3390/v10010034
23. Gunthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral Drugs for Treatment and Prevention of hiv Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. Jama. 2016;316(2):191-210. Doi: 10.1001/jama.2016.8900
24. Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, et al. Adult antiretroviral therapy guidelines 2017. South Afr J hiv Med. 2017;18(1):776. Doi: 10.4102/sajhivmed.v18i1.776
25. Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. cd4:cd8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed hiv-positive patients. J Int aids Soc. 2015;18:20052. Doi: 10.7448/IAS.18.1.20052
26. Bastard JP, Soulie C, Fellahi S, Haim-Boukobza S, Simon A, Katlama C, et al. Circulating interleukin-6 levels correlate with residual hiv viraemia and markers of immune dysfunction in treatment-controlled hiv-infected patients. Antiviral Therapy. 2012;17(5):915-9. Doi: 10.3851/IMP2093
27. Murday AS, Chaudhry S, Pauza CD. Interleukin-18 activates Vgamma9Vdelta2(+) T cells from hiv-positive individuals: recovering the response to phosphoantigen. Immunology. 2017;151(4):385-94. Doi: 10.1111/imm.12735
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Revista Ciencias de la Salud
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio UdeA
Universidad de Antioquia
instacron:Universidad de Antioquia
Revista Ciencias de la Salud, Volume: 17, Issue: 2, Pages: 245-258, Published: AUG 2019

Arias-Pérez, Rubén Darío; Arboleda-Álvarez, Nataly; Sánchez-Gómez, Catalina; Flórez-Alvarez, Lizdany; Marín-Palma, Damariz; Taborda A., Natalia; Hernandez C., Juan

Kasmera. Jan-June, 2021, Vol. 49 Issue 1, p1h, 13 p.

Castro MD, MSc, Gustavo; León MSc, Kevin; Marín-Palma MSc, Damariz; Oyuela MD, Sarita M.; Cataño-Bedoya MD, Esp, Jhon Ubeimar; Duque-Botero MD, Esp, Julieta; Giraldo-Méndez MD, Esp., Diana Patricia; Taborda Sci Doc, Natalia A.; Hernandez Sci Doc, Juan C.; Rugeles Sci Doc, María Teresa; Jaimes MD, Esp., MSC, PhD, Fabián Alberto

Revista Ciencias de la Salud, Volume: 19, Issue: 3, Pages: 55-72, Published: 03 MAY 2022

Gustavo Castro; Kevin León; Damariz Marín-Palma; Sarita M. Oyuela; Jhon Ubeimar Cataño-Bedoya; Julieta Duque-Botero; Diana Patricia Giraldo-Méndez; Natalia A. Taborda; Juan C. Hernandez; María Teresa Rugeles; Fabián Alberto Jaimes

Revista Ciencias de la Salud, Vol 19, Iss 3 (2021)

Ruben Dario Arias Perez; Nataly Arboleda-Álvarez; Catalina Sánchez-Gómez; Lizdany Florez-Alvarez; Damariz Marín-Palma; Natalia A. Taborda; Juan C. Hernandez

Kasmera, Vol 49, Iss 1 (2021)

Marín Palma, Damariz; Taborda, Natalia Andrea; Urcuqui Inchima, Silvio; Hernández, Juan Carlos

Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Repositorio UdeA
Universidad de Antioquia
instacron:Universidad de Antioquia
Iatreia, Volume: 30, Issue: 4, Pages: 423-435, Published: DEC 2017

Damariz Marín-Palma; Jorge H. Tabares-Guevara; María I. Zapata-Cardona; Lizdany Flórez-Álvarez; Lina M. Yepes; Maria T. Rugeles; Wildeman Zapata-Builes; Juan C. Hernandez; Natalia A. Taborda

Molecules, Vol 26, Iss 22, p 6900 (2021)

Marín-Palma, Damariz; Tabares-Guevara, Jorge H.; Taborda, Natalia; Rugeles, Maria T.; Hernandez, Juan C.

Marín-Palma, Damariz; Tabares-Guevara, Jorge H.; Taborda, Natalia; Rugeles, Maria T.; Hernandez, Juan C.

Damariz Marín-Palma; Gustavo A. Castro; Jaiberth A. Cardona-Arias; Silvio Urcuqui-Inchima; Juan C. Hernandez

Frontiers in Immunology, Vol 9 (2018)

Marin-Palma, Damariz; Gonzalez, Juan D.; Narvaez, Jhon F.; Porras, Jazmin; Taborda, Natalia A.; Hernandez, Juan C.

WATER AIR AND SOIL POLLUTION; MAR 2023, 234 3, p138 13p.

Gomez, Diana M.; Tabares-Guevara, Jorge H.; Marin-Palma, Damariz; Hernandez, Juan C.

AIR QUALITY ATMOSPHERE AND HEALTH; OCT 15 2022, 9p.

MARÍN-PALMA, DAMARIZ; TABARES-GUEVARA, JORGE H.; ZAPATA-BUILES, WILDEMAN; HERNANDEZ, JUAN C.; TABORDA, NATALIA A.

Salud Uninorte. 2025 Special Issue, p16-17. 2p.

Loaiza-Ceballos, Maria Camila; Marin-Palma, Damariz; Zapata, Wildeman; Hernandez, Juan C.

AIR QUALITY ATMOSPHERE AND HEALTH; SEP 15 2021, 10p.

Damariz Marín-Palma; Cherilyn M. Sirois; Silvio Urcuqui‐Inchima; Juan C. Hernández

PLoS One
PLoS ONE, Vol 14, Iss 3, p e0214245 (2019)
1. (TDR) WHOWatSPfRaTiTD. Dengue guidelines for diagnosis, treatment, prevention and control. 2009.
2. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328(5979):745–8. pmid:20448183
3. Ng JK, Zhang SL, Tan HC, Yan B, Martinez JM, Tan WY, et al. First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. PLoS pathogens. 2014;10(4):e1004031. pmid:24699622
4. Kuczera D, Assolini JP, Tomiotto-Pellissier F, Pavanelli WR, Silveira GF. Highlights for Dengue Immunopathogenesis: Antibody-Dependent Enhancement, Cytokine Storm, and Beyond. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2018;38(2):69–80. pmid:29443656
5. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. The Journal of infectious diseases. 1998;177(3):778–82 pmid:9498463
6. Lee WL, Liles WC. Endothelial activation, dysfunction and permeability during severe infections. Current opinion in hematology. 2011;18(3):191–6. pmid:21423012
7. Nascimento EJ, Braga-Neto U, Calzavara-Silva CE, Gomes AL, Abath FG, Brito CA, et al. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS One. 2009;4(11):e7892. pmid:19936257
8. Nascimento EJ, Silva AM, Cordeiro MT, Brito CA, Gil LH, Braga-Neto U, et al. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One. 2009;4(8):e6782. pmid:19707565
9. Biswas HH, Gordon A, Nunez A, Perez MA, Balmaseda A, Harris E. Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome. PLoS neglected tropical diseases. 2015;9(9):e0003904. pmid:26334914
11. van Gorp EC, Suharti C, Mairuhu AT, Dolmans WM, van Der Ven J, Demacker PN, et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2002;34(8):1150–3. pmid:11915007
12. Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH. Differential effects of HDL subpopulations on cellular ABCA1-and SR-BI-mediated cholesterol efflux. J Lipid Res. 2005;46(10):2246–53. pmid:16061948
13. Marín-Palma D TN, Urcuqui-Inchima S, Hernández JC. Inflamación y respuesta inmune innata: Participación de las lipoproteínas de alta densidad. IATREIA. 2017 Oct-Dic;30(4):423–35.
14. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem. 2000;275(15):11278–83 pmid:10753938
15. Kameda T, Ohkawa R, Yano K, Usami Y, Miyazaki A, Matsuda K, et al. Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein. Journal of lipids. 2015;2015:592594. pmid:26257958
16. Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A, et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem. 2001;276(37):34480–5. pmid:11432865
17. Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, et al. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016;149(3):306–19. pmid:27329564
18. Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nature reviews Immunology. 2016;16(7):407–20. pmid:27291964
19. Im H, Ammit AJ. The NLRP3 inflammasome: role in airway inflammation. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2014;44(2):160–72. pmid:24118105
20. Feria MG, Taborda NA, Hernandez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1beta, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS One. 2018;13(4):e0192845. pmid:29672590
21. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC infectious diseases. 2008;8:86. pmid:18578883
22. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS immunology and medical microbiology. 2001;30(3):229–33 pmid:11335143
23. Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, Chen NJ, et al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood. 2013;121(1):95–106. pmid:23152543
24. Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood. 2013;122(20):3405–14. pmid:24009231
25. Barrientos-Arenas E, Henao-García V, Giraldo DM, Cardona MM, Urcuqui-Inchima S, Castaño JC, et al. Modulación de los niveles de lipoproteínas de alta densidad y las citoquinas IL-1β e IL-6 en pacientes con dengue. Revista peruana de medicina experimental y salud publica. 2018;35 (1):15–24. pmid:29924262
26. Diseases WHOSPfRaTiT. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. 2009. Available from: http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf
27. Marin-Palma D, Castro GA, Cardona-Arias JA, Urcuqui-Inchima S, Hernandez JC. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression. Frontiers in immunology. 2018;9:1350. pmid:29963050
28. Gomez DM, Urcuqui-Inchima S, Hernandez JC. Silica nanoparticles induce NLRP3 inflammasome activation in human primary immune cells. Innate Immun. 2017;23(8):697–708. pmid:29113588
29. Hernandez JC, Giraldo DM, Paul S, Urcuqui-Inchima S. Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protection. PLoS One. 2015;10(3):e0119844. pmid:25785697
30. Estruch M, Rajamaki K, Sanchez-Quesada JL, Kovanen PT, Oorni K, Benitez S, et al. Electronegative LDL induces priming and inflammasome activation leading to IL-1beta release in human monocytes and macrophages. Biochimica et biophysica acta. 2015;1851(11):1442–9. pmid:26327597
31. Garcia Cordero J, Leon Juarez M, Gonzalez YMJA, Cedillo Barron L, Gutierrez Castaneda B. Caveolin-1 in lipid rafts interacts with dengue virus NS3 during polyprotein processing and replication in HMEC-1 cells. PLoS One. 2014;9(3):e90704. pmid:24643062
32. Martinez-Gutierrez M, Castellanos JE, Gallego-Gomez JC. Statins reduce dengue virus production via decreased virion assembly. Intervirology. 2011;54(4):202–16. pmid:21293097
33. Carro AC, Damonte EB. Requirement of cholesterol in the viral envelope for dengue virus infection. Virus research. 2013;174(1–2):78–87. pmid:23517753
34. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11):2071–7. pmid:18617650
35. Cui L, Lee YH, Kumar Y, Xu F, Lu K, Ooi EE, et al. Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS neglected tropical diseases. 2013;7(8):e2373. pmid:23967362
36. Ekchariyawat P, Hamel R, Bernard E, Wichit S, Surasombatpattana P, Talignani L, et al. Inflammasome signaling pathways exert antiviral effect against Chikungunya virus in human dermal fibroblasts. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2015;32:401–8. pmid:25847693
37. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R, et al. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. Journal of medical virology. 1999;59(3):335–40 pmid:10502266
38. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, Neves-Souza PC, et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology. 2001;204(4):494–507. pmid:11776403
39. Tauseef A, Umar N, Sabir S, Akmal A, Sajjad S, Zulfiqar S. Interleukin-10 as a Marker of Disease Progression in Dengue Hemorrhagic Fever. Journal of the College of Physicians and Surgeons—Pakistan: JCPSP. 2016;26(3):187–90. pmid:26975948
40. Suharti C, van Gorp EC, Dolmans WM, Setiati TE, Hack CE, Djokomoeljanto R, et al. Cytokine patterns during dengue shock syndrome. European cytokine network. 2003;14(3):172–7 pmid:14656693
41. Kuno G, Bailey RE. Cytokine responses to dengue infection among Puerto Rican patients. Memorias do Instituto Oswaldo Cruz. 1994;89(2):179–82 pmid:7885241
42. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, Lu MY, et al. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol. 2006;177(5):3185–92 pmid:16920957
43. Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, et al. A three-component biomarker panel for prediction of dengue hemorrhagic fever. The American journal of tropical medicine and hygiene. 2012;86(2):341–8. pmid:22302872
44. Eppy Suhendro, Nainggolan L, Rumende CM. The Differences Between Interleukin-6 and C-reactive Protein Levels Among Adult Patients of Dengue Infection with and without Plasma Leakage. Acta medica Indonesiana. 2016;48(1):3–9 pmid:27241538
45. Liu W, Yin Y, Zhou Z, He M, Dai Y. OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation. Inflammation research: official journal of the European Histamine Research Society [et al]. 2014;63(1):33–43. pmid:24121974
46. Soto-Acosta R, Mosso C, Cervantes-Salazar M, Puerta-Guardo H, Medina F, Favari L, et al. The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology. 2013;442(2):132–47. pmid:23642566
47. Kellner-Weibel G, Yancey PG, Jerome WG, Walser T, Mason RP, Phillips MC, et al. Crystallization of free cholesterol in model macrophage foam cells. Arterioscler Thromb Vasc Biol. 1999;19(8):1891–8 pmid:10446067
48. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–61. pmid:20428172
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia